Related Experiment Video
Updated: Jun 23, 2026

Simultaneous Brightfield, Fluorescence, and Optical Coherence Tomographic Imaging of Contracting Cardiac Trabeculae Ex Vivo
Published on: October 2, 2021
BeatProfiler: Multimodal In Vitro Analysis of Cardiac Function Enables Machine Learning Classification of Diseases
Youngbin Kim1, Kunlun Wang1, Roberta I Lock1
1Department of Biomedical EngineeringColumbia University New York NY 10032 USA.
BeatProfiler offers a faster, more accurate way to analyze cardiac function and calcium handling in vitro. This tool aids in deep phenotyping and classifying cardiac diseases and drug responses with high accuracy.
Area of Science:
- Cardiovascular Biology
- Biophysics
- Computational Biology
Background:
- Cardiac contractile function and calcium handling are crucial for understanding heart physiology and disease.
- Existing analytical methods for these metrics are often slow, error-prone, or require specialized resources.
- There is a need for efficient and accurate tools for in vitro cardiac model analysis.
Purpose of the Study:
- To develop and validate BeatProfiler, a suite of tools for quantifying cardiac contractile function and calcium handling in vitro.
- To apply machine learning for deep phenotyping and classification of cardiac disease models and drug responses.
- To improve the speed, accuracy, and robustness of cardiac function analysis.
Main Methods:
- BeatProfiler was developed to analyze contractile and calcium signals from various in vitro cardiac models.
- Benchmarking was performed against existing tools to assess accuracy, robustness, and speed.
- Machine learning models, including feature-based ML and TCN-BiLSTM, were employed for classification tasks.
- Grad-CAM was used to visualize drug perturbation signatures in calcium signals.
Main Results:
- BeatProfiler demonstrated a 7 to 50-fold increase in analysis speed compared to existing methods.
- It showed improved sensitivity and reduced false positives in signal detection.
- BeatProfiler accurately classified restrictive cardiomyopathy models with 98% accuracy and cardiac drugs with 96% accuracy.
- Key features distinguishing disease states and drug effects were identified.
Conclusions:
- BeatProfiler significantly enhances the efficiency and accuracy of in vitro cardiac studies.
- The tool facilitates rapid phenotyping and objective classification of cardiac diseases and drug responses.
- BeatProfiler is expected to advance research into cardiac health, disease mechanisms, and therapeutic interventions.
More Related Videos
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
09:43Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025